ArticleBMC musculoskeletal disorders2026
Risk factors and early onset predictors of contralateral hip fractures following initial treatment of the other hip fracture.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundThis study aims to investigate the risk factors and onset timing of second contralateral hip fractures (SHFx) following initial femoral fractures, with a particular focus on early events occurring within one year.
methodsThis retrospective study utilized a nationwide hospital claims database (Medical Data Vision, MDV) covering over 30% of all Diagnosis Procedure Combination (DPC) hospitals in Japan. MDV data combining patients who had visited a healthcare facility for osteoporosis with fractures (International Classification of Diseases, 10th Revision [ICD-10] code M80) or femoral fractures (ICD-10 code S72) were used. Patients aged 40 years and older who underwent bipolar hip arthroplasty or open reduction and internal fixation between April 2008 and September 2024 were included (n = 370,227). Clinical and demographic data were collected, including comorbidities and medications related to QFracture, FRAX, and fall risk.
resultsThe incidence of early second contralateral hip fractures (eSHFx) was 2.7% (n = 10,136). Multivariate logistic regression identified female, age (70-79, 80-89, ≥ 90 years), Bone Mass Index (BMI) < 18.5 kg/m2, Charlson Comorbidity Index (CCI) = 1 point, dementia, delirium, fracture history, steroid use, and sleeping pill use as significant risk factors for eSHFx. Among patients who developed SHFx, male, age ≥ 90 years, BMI < 18.5 kg/m2, CCI (1, ≥ 3 points), dementia, delirium, steroid use, and sleeping pill use were significantly associated with early rather than late onset. Fall-related factors were risk factors for eSHFx and factors that predisposed to eSHFx. Female was a risk factor for eSHFx, but the timing of SHFx was late.
conclusionThis study identified risk factors for eSHFx and factors influencing their timing. It is crucial to determine the optimal timing and method of intervention for each patient to select the most appropriate therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.